Rare diseases
Investigational molecules
Locations
Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
ItalyStudy on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments
ItalyStudy of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
ItalyStudy of Tislelizumab, Surzebiclimab, and LBL-007 for Patients with Recurrent or Metastatic Head and Neck Cancer
ItalyStudy to Test BI 765845 for Patients with Heart Attack
ItalyStudy of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors
ItalyStudy on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)
ItalyStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
ItalyStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
ItalyStudy Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection
ItalyStudy on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis
ItalyStudy on Anastrozole, Letrozole, Exemestane, and Tamoxifen for Women Aged 70+ with Early Stage Breast Cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
